CC
SZYM

Cannell Capital’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Cannell Capital’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-99,515
Closed -$1.16M – 71
2014
Q1 		$1.16M Buy
+99,515
New +$1.17M 0.41% 43

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cannell Capital's SZYM Position: Q2 2014 in Review

Cannell Capital sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2014, closing a stake of 99,515 shares — an estimated $1.16M sold.

Cannell Capital first reported a position in SZYM in Q1 2014 and held it in 1 quarter. The position peaked at $1.16M in Q1 2014. 124 funds tracked by Wall St. Rank hold SZYM as of Q2 2014.

  • Cannell Capital reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Cannell Capital sold 99,515 SOLAZYME INC COM STK (DE) shares in Q2 2014, an estimated $1.16M.
  • Cannell Capital first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • Cannell Capital's SOLAZYME INC COM STK (DE) position peaked at $1.16M in Q1 2014.
  • 124 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2014.

Based on Cannell Capital's 13F filing for Q2 2014, filed 14 Aug 2014.